Associate staff scientist,
Weizmann Institute of Science
rehovot, HaDarom, Israel
Dr. Tali Feferman has completed her Ph.D. in Molecular Biology at the Macquarie University and Postdoctoral Training at The Heart Research Institute in Sydney Australia. She has then joined the Weizmann Institute of Science in 2000. Her initial interest involved exploring the mechanism of action and immunomodulation of Myasthenia Gravis (MG) and its model experimental autoimmune MG (EAMG). In recent years her interest shifted addressing mainly focused on addressing questions important for optimizing cancer immunotherapy in-vivo using cutting-edge imaging microscopic techniques in live mice. Recently, Tali joined the lab of Dr. Rony Dahan studying the role of IgG Fc glycosylation in cancer and in COVID19. She is an Associate Research Scientist at the Weizmann Institute of Science
Disclosure information not submitted.
Wednesday, June 22, 2022
3:45 PM – 4:00 PM PT
